跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
CYCLOSPORINE - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
CYCLOSPORINE
Authorized
STANDARD
CYCLOSPORINE
Edenbridge Pharmaceuticals, LLC
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
98be531555ae6e24
Company
Edenbridge Pharmaceuticals, LLC
Type
Standard
Approval Details
Approval Id
98be531555ae6e24
Drug Approval Canada Name
CYCLOSPORINE
Product Name
CYCLOSPORINE
Status
Dormant
Status Date
2025-03-07
Original Market Date
2022-02-03
Din
02495805
Drug Class
Human
Dosage Form
Capsule
Route Of Administration
Oral
Schedule
Prescription
Ahfs
90:28.28.92
Atc Original
L04AD01 CICLOSPORIN
Atc Name
l 04 ad 01
Aig Number
0115996002
Company Name
Edenbridge Pharmaceuticals, LLC
Company Address
1 Upper Pond Road, Suite D250, Parsipanny, New Jersey, United States, 07054
Company Detail Path
/organization/edenbridge-pharmaceuticals-llc
Company Information
Pharmaceutical Company Name
Edenbridge Pharmaceuticals, LLC
Country Name
United States
Province Name
New Jersey
City Name
parsippany,new jersey,country_us
Address
1 Upper Pond Rd Ste D250
Active Ingredients
CYCLOSPORINE
25 MG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
98be531555ae6e24
Type
Standard
Back to Health Canada Approvals